A Phase 2 Study of Home Care Following Autologous Hematopoietic Stem Cell Transplantation
Launched by DUKE UNIVERSITY · Sep 10, 2018
Trial Information
Current as of August 20, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the well-being of caregivers who look after patients receiving a specific type of treatment called autologous hematopoietic stem cell transplantation, which is often used for cancer or certain non-cancer illnesses. The study will compare how caregivers feel and manage their responsibilities when patients receive care at home versus standard care in a medical facility. Caregivers play a vital role in supporting patients, and understanding their experiences can help improve care for both patients and their caregivers.
To qualify for the study, patients must be between 18 and 80 years old, scheduled for this type of transplant, and able to communicate in English. They also need to have a suitable home environment for recovery. Caregivers must be identified by the patient and should be able to provide necessary support, like driving and helping with daily tasks. There are no specific exclusions for caregivers. Participants can expect to share their experiences, which will help researchers understand how home care impacts the well-being of those caring for patients during recovery.
Gender
ALL
Eligibility criteria
- Patient Inclusion Criteria:
- • Scheduled to undergo an autologous hematopoietic stem cell transplant for any cancer or non-cancer illness
- • Age 18-80 years
- • Karnofsky Performance Scale KPS\> 80
- • Able to read/write English
- • A home that is deemed, upon inspection, in suitable condition to serve as a medical home, within a 90-minute driving distance of Duke
- Patient Exclusion Criteria:
- • Lack of a caregiver
- • Pregnant women
- • Patients with a documented active infection prior to starting their preparative regimen. This includes grade 3 or higher viral, bacterial, or fungal infection.
- • Use of homeopathic medications, prebiotics, or probiotics that may impact gut microbiota
- Caregiver Inclusion Criteria:
- • Identified by patient as their primary caregiver
- • Meet standard clinical criteria for being a caregiver (able to drive and take care of patient)
- • Age 18-80 years
- Caregiver Exclusion Criteria:
- • None
About Duke University
Duke University, a leading academic and research institution located in Durham, North Carolina, is renowned for its commitment to advancing healthcare through innovative clinical research. With a strong emphasis on interdisciplinary collaboration, Duke conducts a wide array of clinical trials aimed at developing cutting-edge therapies and improving patient outcomes across various medical fields. The university's Clinical Research Institute provides comprehensive support for trial design, implementation, and regulatory compliance, ensuring that all research adheres to the highest ethical and scientific standards. Duke’s dedication to translating research findings into effective clinical practices underscores its role as a pivotal contributor to the global medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Durham, North Carolina, United States
Durham, North Carolina, United States
Patients applied
Trial Officials
Anthony Sung, MD
Principal Investigator
Duke Health
Nelson Chao, MD
Principal Investigator
Duke Health
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials